Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 3
1974 2
1975 9
1976 8
1977 3
1978 3
1979 2
1980 1
1981 2
1982 3
1983 4
1984 2
1985 5
1986 4
1987 3
1988 8
1989 6
1990 3
1991 1
1992 2
1993 3
1994 4
1995 4
1996 4
1997 4
1998 3
1999 24
2000 3
2001 9
2002 6
2003 15
2004 8
2005 10
2006 9
2007 13
2008 6
2009 12
2010 7
2011 18
2012 10
2013 11
2014 11
2015 18
2016 10
2018 3
2019 2
2020 1
2023 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

287 results

Results by year

Filters applied: . Clear all
Page 1
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study.
Gisslinger H, Klade C, Georgiev P, Krochmalczyk D, Gercheva-Kyuchukova L, Egyed M, Rossiev V, Dulicek P, Illes A, Pylypenko H, Sivcheva L, Mayer J, Yablokova V, Krejcy K, Grohmann-Izay B, Hasselbalch HC, Kralovics R, Kiladjian JJ; PROUD-PV Study Group. Gisslinger H, et al. Lancet Haematol. 2020 Mar;7(3):e196-e208. doi: 10.1016/S2352-3026(19)30236-4. Epub 2020 Jan 31. Lancet Haematol. 2020. PMID: 32014125 Clinical Trial.
Multiple Myeloma in Pregnancy--A Review of the Literature and a Case Series.
Jurczyszyn A, Olszewska-Szopa M, Vesole AS, Vesole DH, Siegel DS, Richardson PG, Paba-Prada C, Callander NS, Huras H, Skotnicki AB. Jurczyszyn A, et al. Among authors: skotnicki ab. Clin Lymphoma Myeloma Leuk. 2016 Mar;16(3):e39-45. doi: 10.1016/j.clml.2015.11.020. Epub 2015 Dec 2. Clin Lymphoma Myeloma Leuk. 2016. PMID: 26847816 Review.
[Daratumumab--breakthrough drug in multiple myeloma therapy].
Jurczyszyn A, Kosmaczewska A, Skotnicki AB. Jurczyszyn A, et al. Among authors: skotnicki ab. Postepy Hig Med Dosw (Online). 2014 Nov 25;68:1352-60. doi: 10.5604/17322693.1129819. Postepy Hig Med Dosw (Online). 2014. PMID: 25531698 Free article. Review. Polish.
Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients.
Jurczyszyn A, Olszewska-Szopa M, Hungria V, Crusoe E, Pika T, Delforge M, Leleu X, Rasche L, Nooka AK, Druzd-Sitek A, Walewski J, Davila J, Caers J, Maisnar V, Gertz M, Gentile M, Fantl D, Mele G, Vesole DH, Yee AJ, Shustik C, Lentzsch S, Zweegman S, Gozzetti A, Skotnicki AB, Castillo JJ. Jurczyszyn A, et al. Among authors: skotnicki ab. Leuk Lymphoma. 2016 Sep;57(9):2071-6. doi: 10.3109/10428194.2015.1128542. Epub 2016 Jan 4. Leuk Lymphoma. 2016. PMID: 26726867
Aspergillus endocarditis in a 33-year-old patient with bone marrow aplasia.
Olszanecka A, Wojciechowska W, Mensah-Glanowska P, Piątkowska-Jakubas B, Skotnicki A, Czarnecka D. Olszanecka A, et al. Among authors: skotnicki a. Pol Arch Med Wewn. 2015;125(7-8):586-7. Epub 2015 Jun 11. Pol Arch Med Wewn. 2015. PMID: 26075929 Free article. No abstract available.
Efficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia A.
Mahlangu J, Kuliczkowski K, Karim FA, Stasyshyn O, Kosinova MV, Lepatan LM, Skotnicki A, Boggio LN, Klamroth R, Oldenburg J, Hellmann A, Santagostino E, Baker RI, Fischer K, Gill JC, P'Ng S, Chowdary P, Escobar MA, Khayat CD, Rusen L, Bensen-Kennedy D, Blackman N, Limsakun T, Veldman A, St Ledger K, Pabinger I; AFFINITY Investigators. Mahlangu J, et al. Among authors: skotnicki a. Blood. 2016 Aug 4;128(5):630-7. doi: 10.1182/blood-2016-01-687434. Epub 2016 Jun 21. Blood. 2016. PMID: 27330001 Free PMC article. Clinical Trial.
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia.
Awan FT, Hillmen P, Hellmann A, Robak T, Hughes SG, Trone D, Shannon M, Flinn IW, Byrd JC; LUCID trial investigators. Awan FT, et al. Br J Haematol. 2014 Nov;167(4):466-77. doi: 10.1111/bjh.13061. Epub 2014 Aug 8. Br J Haematol. 2014. PMID: 25130401 Free article. Clinical Trial.
287 results